Lu Han

1.7k total citations
50 papers, 1.2k citations indexed

About

Lu Han is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Lu Han has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Biomedical Engineering and 11 papers in Cancer Research. Recurrent topics in Lu Han's work include RNA Interference and Gene Delivery (7 papers), MicroRNA in disease regulation (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Lu Han is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), MicroRNA in disease regulation (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Lu Han collaborates with scholars based in China, United Kingdom and United States. Lu Han's co-authors include Tao Gong, Sanjun Shi, Xun Sun, Zhixiang Yuan, Zhirong Zhang, Chunai Gong, Rong Wang, Zhirong Zhang, Lili He and Xun Sun and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Lu Han

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Han China 17 550 353 277 244 203 50 1.2k
Galia Tiram Israel 17 568 1.0× 430 1.2× 389 1.4× 212 0.9× 175 0.9× 21 1.4k
Rang‐Woon Park South Korea 18 717 1.3× 359 1.0× 398 1.4× 191 0.8× 154 0.8× 39 1.6k
Shiran Ferber Israel 16 448 0.8× 416 1.2× 299 1.1× 180 0.7× 93 0.5× 21 1.1k
Tingting Lin China 12 467 0.8× 373 1.1× 409 1.5× 206 0.8× 86 0.4× 47 1.1k
Gijung Kwak South Korea 16 683 1.2× 482 1.4× 335 1.2× 119 0.5× 176 0.9× 27 1.4k
Alexandros Marios Sofias Germany 17 494 0.9× 505 1.4× 447 1.6× 135 0.6× 97 0.5× 32 1.2k
Sol Shin South Korea 16 447 0.8× 352 1.0× 186 0.7× 82 0.3× 179 0.9× 21 892
Huining He China 19 573 1.0× 499 1.4× 530 1.9× 124 0.5× 113 0.6× 44 1.3k
Ai Zhuang China 20 641 1.2× 274 0.8× 125 0.5× 182 0.7× 313 1.5× 49 1.3k
Christian Marín‐Müller United States 7 474 0.9× 250 0.7× 288 1.0× 200 0.8× 230 1.1× 12 1.2k

Countries citing papers authored by Lu Han

Since Specialization
Citations

This map shows the geographic impact of Lu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Han more than expected).

Fields of papers citing papers by Lu Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Han. The network helps show where Lu Han may publish in the future.

Co-authorship network of co-authors of Lu Han

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Han. A scholar is included among the top collaborators of Lu Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Han. Lu Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Dan, Xueru Zhao, Yongxiang Zhang, et al.. (2025). DIORS: Enhancing drug-target interaction prediction via structure and signature integrated-driven approach and discovering potential targeted molecules. Pharmacological Research. 215. 107710–107710. 1 indexed citations
3.
Shen, Cheng, Yan Ma, Fenglan Huang, et al.. (2025). Mesenchymal Stem Cell-Derived Exosomes for Ocular Diseases: Therapeutic Mechanisms and Clinical Perspectives. International Journal of Nanomedicine. Volume 20. 14521–14550.
6.
Sun, Zhicheng, Chenyang Liu, Rui Ma, et al.. (2024). Strong flexible conductive hydrogel based on adaptive temperature and humidity characteristics. Surfaces and Interfaces. 51. 104794–104794. 3 indexed citations
7.
Fu, Xiaomin, et al.. (2024). Combination therapy using low‐dose anlotinib and immune checkpoint inhibitors for extensive‐stage small cell lung cancer. SHILAP Revista de lepidopterología. 3(6). e155–e155. 2 indexed citations
8.
Sun, Zhiyuan, Xin Qi, Jianyu Wang, et al.. (2024). How do drunk-driving events escalate into drunk-driving crashes? An empirical analysis of Beijing from a spatiotemporal perspective. International Journal of Injury Control and Safety Promotion. 31(2). 256–272. 1 indexed citations
9.
Han, Lu, et al.. (2023). Competitive relationship between electrical degradation and healing in self‐healing dielectric polymers. SHILAP Revista de lepidopterología. 6(4). 231–236. 4 indexed citations
10.
Zhao, Yue, Wang Xiao-ling, Lu Han, et al.. (2023). Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery. Pharmaceutics. 15(7). 2011–2011. 14 indexed citations
11.
Zhang, Peigen, Yujie Zhu, Mingcong Yang, et al.. (2023). Autonomous indication of electrical degradation in polymers. Nature Materials. 23(2). 237–243. 19 indexed citations
12.
Wang, Shuo, Puyang Gong, Jian Gu, et al.. (2022). Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics. SHILAP Revista de lepidopterología. 107 indexed citations
13.
Han, Lu, Naiqing Ding, Li Li, et al.. (2022). Hepatoid adenocarcinoma of the duodenal papilla with hepatic metastases: A case report and literature review. Frontiers in Oncology. 12. 948892–948892. 3 indexed citations
14.
Jiang, Xinwei, Xia Li, Hua Nie, et al.. (2021). Baking of methionine-choline deficient diet aggravates testis injury in mice. Food and Chemical Toxicology. 154. 112245–112245. 4 indexed citations
15.
Liu, Hongmei, Lu Han, Yan Ren, et al.. (2021). Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Colloids and Surfaces B Biointerfaces. 209(Pt 1). 112163–112163. 49 indexed citations
16.
Dong, Bo, et al.. (2021). Catamenial pneumothorax with bubbling up on the diaphragmatic defects: a case report. BMC Women s Health. 21(1). 167–167. 5 indexed citations
17.
Cui, Xinyue, Liqun Yang, Qin Hu, et al.. (2021). Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy. International Journal of Pharmaceutics. 608. 121091–121091. 27 indexed citations
18.
Gong, Chunai, Xiaoyan Yu, Yan Wu, et al.. (2020). Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy. Journal of Nanobiotechnology. 18(1). 92–92. 158 indexed citations
19.
Matthieu, Monica M., et al.. (2014). Personal and Professional Knowledge of and Experience With Suicide and Suicide Prevention Among Stakeholders in Clinical and Community Practice. Social Work in Mental Health. 12(5-6). 443–456. 1 indexed citations
20.
Li, Xia, Qing Xu, Yuhui Wu, et al.. (2014). A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma. Carcinogenesis. 35(6). 1362–1370. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026